Viatris Earnings, Revenue miss in Q1 By Investing.com

Viatris reported on Friday first quarter earnings that missed analysts’ forecasts and revenue that fell short of expectations.

Viatris announced earnings per share of $1.08 on revenue of $3.62B. Analysts polled by Investing.com anticipated EPS of $1.24 on revenue of $4.17B.

Viatris shares are down 5.13% from the beginning of the year and are trading at $13.59 , down-from-52-week-high.They are under-performing the FTSE 100 which is up 2.95% from the start of the year.

Viatris follows other major Healthcare sector earnings this month

Viatris’s report follows an earnings missed by Merck&Co on February 4, who reported EPS of $1.32 on revenue of $12.51B, compared to forecasts EPS of $1.38 on revenue of $12.67B.

Medtronic had beat expectations on February 23 with third quarter EPS of $1.29 on revenue of $7.78B, compared to forecast for EPS of $1.15 on revenue of $7.77B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar